Prescription Required
Metglib Tablet is a mix of Glipizide and metformin anti-diabetic drugs formulated to stabilize blood glucose levels in adults suffering from type 2 diabetes. It's worth noting that it is not recommended for type 1 diabetes.
This combination leverages the combined power of Glipizide and Metformin. Glipizide triggers insulin production by the pancreas, assisting glucose breakdown. On the other hand, Metformin enhances the body's sensitivity to insulin and curtails excessive glucose generation in the liver.
It is typically consumed during meals to bolster effectiveness. If a dose is overlooked, take it as soon as you recall. Nevertheless, if the upcoming scheduled dose is imminent, disregard the forgotten one. Prevent doubling up in an attempt to compensate for a forgotten dose.
Regular side effects encompass stomach discomfort, queasiness, diarrhoea, headache, or minor cold symptoms. However, if you experience serious hypoglycaemia (extreme fatigue, blurry vision, confusion, etc), indications of heart complications, or symptoms of lactic acidosis (uncommon muscle pain, difficulty breathing), seek urgent medical care.
Convey to your medical expert about any allergies to Glipizide, Metformin, or related compounds. Discuss your health history, particularly regarding kidney problems, heart diseases, or if you are over 80 years of age. In cases of vomiting, diarrhoea, or fever, connect with your doctor immediately to prevent dehydration.
If you miss a dose, take it immediately. However, if the next planned dose is near, it is recommended to skip the missed dosage. Avoid doubling up in an attempt to compensate for a missed dosage.
It is dangerous to mix medicine with alcohol, as it may lead to negative side effects and heightened risks.
It could be risky during pregnancy. Consultation with your doctor is necessary to assess the benefits and possible risks before taking it.
Medication usage while breastfeeding is possibly unsafe, with limited evidence suggesting potential harm to the baby through breast milk.
Medicine usage in kidney disease should be cautious, with dose adjustments and consistent monitoring of kidney function recommended, particularly in severe kidney disease.
Proceed with caution in liver disease withmedicine. Starting doses should be low in mild to moderate liver disease, and its usage is discouraged in severe liver disease.
Analogous to the solitary Glipizide, yet amalgamated with Metformin, this synthesis offers twin frameworks for blood sugar regulation in type 2 diabetes. Glipizide triggers insulin discharge, while Metformin diminishes glucose formation.
Type 2 diabetes mellitus is a chronic condition that affects how the body regulates and uses sugar (glucose) as a fuel. It occurs when the body becomes resistant to insulin, a hormone that helps glucose enter the cells, or when the pancreas cannot produce enough insulin. As a result, the blood sugar levels become too high and can cause damage to various organs and tissues.
Yes, the use of Metglib can cause Vitamin B12 deficiency on long-term use. It interferes with absorption of Vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems and the patient can feel a tingling sensation and numbness in the hands and feet, weakness, urinary problems, change in mental status and difficulty in maintaining balance (ataxia). To avoid such problems, some researchers suggest an intake of Vitamin B12 from outside sources at least once every year.
No, it is not safe to take Metglib along with alcohol, as it may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
The use of Metglib should be avoided in patients with known allergy to any of the components or excipients of this medicine. It should also be avoided in patients with moderate to severe kidney disease and in patients with underlying metabolic acidosis including diabetic ketoacidosis.
The use of Metglib is associated with common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, headache and upper respiratory tract infection. Its use can also lead to serious but rare side effects like lactic acidosis. On long-term use, it can also lead to Vitamin B12 deficiency.
Yes, the use of Metglib can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of the blood sugar level is important. Always carry some glucose tablets, honey or fruit juice with you.
Yes, the use of Metglib can lead to lactic acidosis. It is a medical emergency which is caused by increased levels of lactic acid in the blood. It is also known as MALA (Metformin associated lactic acidosis). It is a rare side effect associated with the use of metformin and therefore, it is avoided in patients with underlying kidney disease, old age patients or who take large amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feeling of cold in arms and legs, difficulty in breathing, nausea, vomiting, stomach pain or slow heart rate. If you have these symptoms, stop taking Metglib and immediately consult your doctor.
Metglib is a combination of two medicines: Glipizide and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glipizide lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of type 1 DM.
Content Updated on
Saturday, 27 January, 2024Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA